论文信息 - 651O Phase II trial of pembrolizumab (P) in combination with sEphB4-HSA (B4) in previously treated metastatic urothelial carcinoma (mUC) - 字舞流文

651O Phase II trial of pembrolizumab (P) in combination with sEphB4-HSA (B4) in previously treated metastatic urothelial carcinoma (mUC)

S. Groshen | T. Dorff | D. Quinn | N. Vogelzang | R. Dreicer | D. Tsao-Wei | E. Burgess | S. Sadeghi | M. Devitt | M. Parikh | P. Lara | A. Jackovich | I. Gill | S. K. Pål | R. Parikh | I. Siddiqi | P. Gill